– New Exploratory Findings from 18-Month Analysis of HELIOS-A Suggest that Treatment with Investigational Vutrisiran May Benefit Patients with Hereditary ATTR (hATTR) Amyloidosis and Cardiac Involvement  – Improvements in NT-proBNP and Echocardiographic Parameters Seen in Cardiac Subpopulation  – Reductions in […]